Literature DB >> 20422465

MMP-9 gene ablation and TIMP-4 mitigate PAR-1-mediated cardiomyocyte dysfunction: a plausible role of dicer and miRNA.

Paras Kumar Mishra1, Naira Metreveli, Suresh C Tyagi.   

Abstract

Although matrix metalloproteinase-9 (MMP-9) is involved in cardiomyocytes contractility dysfunction, tissue inhibitor of metalloproteinase-4 (TIMP-4) mitigates the effect of MMP-9, and proteinase-activated receptor-1 (PAR-1, a G-protein couple receptor, GPCR) is involved in the signaling cascade of MMP-9-mediated cardiac dysfunction, the mechanism(s) are unclear. To test the hypothesis that induction of dicer and differential expression of microRNAs (miRNAs) contribute, in part, to the down regulation of sarcoplasmic reticulum calcium ATPase isoform 2a (serca-2a) in MMP-9 and PAR-1-mediated myocytes dysfunction, ventricular cardiomyocytes were isolated from C57BL/6J mice and treated with 3 ng/ml of MMP-9, 12 ng/ml of TIMP-4, and 10 and 100 microM of PAR-1 antagonist with MMP-9. Specific role of MMP-9 was determined by using MMP-9 knock out (MMP-9KO) and their corresponding control (FVB) mice. Ion Optics video-edge detection system and Fura 2-AM loading were used for determining the contractility and calcium release from cardiomyocytes. Quantitative and semi-quantitative PCR were used to determine the expression of dicer, TIMP-4 and serca-2a. miRNA microarrays were used for assessing the expression of different miRNAs between MMP-9KO and FVB cardiomyocytes. The results suggest that MMP-9 treatment attenuates the voltage-induced contraction of primary cardiomyocytes while TIMP-4, an inhibitor of MMP-9, reverses the inhibition. MMP-9 treatment is also associated with reduced Ca(2+) transients. This effect is blocked by a PAR-1 antagonist, suggesting that PAR-1 mediates this effect. The effect is not as great at high concentrations (100 microM) perhaps due to mild toxicity. The PAR-1 antagonist effect did not affect calcium transients unlike TIMP-4. Interestingly, we show that MMP-KO myocytes contract more rapidly and release more Ca(2+) than FVB. The relevant RNA species serca-2a is induced and dicer is inhibited. There is selective inhibition of miR-376b and over-expression of miR-1, miR-26a, miR-30d, and miR-181c in MMP-9KO that are implicated in regulation of G-PCR and calcium handling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20422465      PMCID: PMC2921878          DOI: 10.1007/s12013-010-9084-1

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  19 in total

Review 1.  Proteinase-activated receptors.

Authors:  S R Macfarlane; M J Seatter; T Kanke; G D Hunter; R Plevin
Journal:  Pharmacol Rev       Date:  2001-06       Impact factor: 25.468

Review 2.  Metalloproteinase in myocardial adaptation and maladaptation.

Authors:  Suresh C Tyagi; Brian D Hoit
Journal:  J Cardiovasc Pharmacol Ther       Date:  2002-10       Impact factor: 2.457

Review 3.  Emerging role of microRNAs in cardiovascular biology.

Authors:  Michael V G Latronico; Daniele Catalucci; Gianluigi Condorelli
Journal:  Circ Res       Date:  2007-12-07       Impact factor: 17.367

4.  Signaling properties and functions of two distinct cardiomyocyte protease-activated receptors.

Authors:  A Sabri; G Muske; H Zhang; E Pak; A Darrow; P Andrade-Gordon; S F Steinberg
Journal:  Circ Res       Date:  2000-05-26       Impact factor: 17.367

5.  Protease-activated receptor and endothelial-myocyte uncoupling in chronic heart failure.

Authors:  Karni S Moshal; Neetu Tyagi; Brooke Henderson; Alexander V Ovechkin; Suresh C Tyagi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-01-28       Impact factor: 4.733

Review 6.  Matrix metalloproteinases in destructive pulmonary pathology.

Authors:  P T G Elkington; J S Friedland
Journal:  Thorax       Date:  2005-10-14       Impact factor: 9.139

7.  Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes.

Authors:  Gang Ye; Naira S Metreveli; Rajakumar V Donthi; Shen Xia; Ming Xu; Edward C Carlson; Paul N Epstein
Journal:  Diabetes       Date:  2004-05       Impact factor: 9.461

8.  Inhibition of matrix metalloproteinases prevents peroxynitrite-induced contractile dysfunction in the isolated cardiac myocyte.

Authors:  H León; I Baczkó; G Sawicki; P E Light; R Schulz
Journal:  Br J Pharmacol       Date:  2007-12-10       Impact factor: 8.739

9.  Accelerated onset of heart failure in mice during pressure overload with chronically decreased SERCA2 calcium pump activity.

Authors:  Jo El J Schultz; Betty J Glascock; Sandra A Witt; Michelle L Nieman; Kalpana J Nattamai; Lynne H Liu; John N Lorenz; Gary E Shull; Thomas R Kimball; Muthu Periasamy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-11-20       Impact factor: 4.733

10.  Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure.

Authors:  Jian-Fu Chen; Elizabeth P Murchison; Ruhang Tang; Thomas E Callis; Mariko Tatsuguchi; Zhongliang Deng; Mauricio Rojas; Scott M Hammond; Michael D Schneider; Craig H Selzman; Gerhard Meissner; Cam Patterson; Gregory J Hannon; Da-Zhi Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-06       Impact factor: 11.205

View more
  21 in total

1.  Cardiac stem cell niche, MMP9, and culture and differentiation of embryonic stem cells.

Authors:  Paras Kumar Mishra; Nicholas John Kuypers; Shree Ram Singh; Noel Diaz Leiberh; Vishalakshi Chavali; Suresh C Tyagi
Journal:  Methods Mol Biol       Date:  2013

2.  Generating double knockout mice to model genetic intervention for diabetic cardiomyopathy in humans.

Authors:  Vishalakshi Chavali; Shyam Sundar Nandi; Shree Ram Singh; Paras Kumar Mishra
Journal:  Methods Mol Biol       Date:  2014

3.  MicroRNA let-7 establishes expression of beta2-adrenergic receptors and dynamically down-regulates agonist-promoted down-regulation.

Authors:  Wayne C H Wang; Aster H Juan; Alfredo Panebra; Stephen B Liggett
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-29       Impact factor: 11.205

Review 4.  Cardiac matrix: a clue for future therapy.

Authors:  Paras Kumar Mishra; Srikanth Givvimani; Vishalakshi Chavali; Suresh C Tyagi
Journal:  Biochim Biophys Acta       Date:  2013-09-17

5.  Exercise mitigates homocysteine - β2-adrenergic receptor interactions to ameliorate contractile dysfunction in diabetes.

Authors:  Paras Kumar Mishra; Olubusayo Awe; Naira Metreveli; Natia Qipshidze; Irving G Joshua; Suresh C Tyagi
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-05-22

6.  Fibrinogen alters mouse brain endothelial cell layer integrity affecting vascular endothelial cadherin.

Authors:  Nino Muradashvili; Neetu Tyagi; Reeta Tyagi; Charu Munjal; David Lominadze
Journal:  Biochem Biophys Res Commun       Date:  2011-09-02       Impact factor: 3.575

7.  Tocotrienols confer resistance to ischemia in hypercholesterolemic hearts: insight with genomics.

Authors:  Somak Das; Subhendu Mukherjee; Istvan Lekli; Narasimman Gurusamy; Jayeeta Bardhan; Utpal Raychoudhury; Runu Chakravarty; Sandip Banerji; Anne A Knowlton; Dipak K Das
Journal:  Mol Cell Biochem       Date:  2011-09-15       Impact factor: 3.396

8.  Attenuation of beta2-adrenergic receptors and homocysteine metabolic enzymes cause diabetic cardiomyopathy.

Authors:  Paras Kumar Mishra; Srikanth Givvimani; Naira Metreveli; Suresh C Tyagi
Journal:  Biochem Biophys Res Commun       Date:  2010-09-15       Impact factor: 3.575

9.  Fibrosis-Related Gene Expression in Single Ventricle Heart Disease.

Authors:  Stephanie J Nakano; Austine K Siomos; Anastacia M Garcia; Hieu Nguyen; Megan SooHoo; Csaba Galambos; Karin Nunley; Brian L Stauffer; Carmen C Sucharov; Shelley D Miyamoto
Journal:  J Pediatr       Date:  2017-10-16       Impact factor: 4.406

10.  Distinctive profile of IsomiR expression and novel microRNAs in rat heart left ventricle.

Authors:  Mary K McGahon; Janet M Yarham; Aideen Daly; Jasenka Guduric-Fuchs; Lyndsey J Ferguson; David A Simpson; Anthony Collins
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.